Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?

被引:0
|
作者
Kim, S. [1 ]
Kang, D. H. [1 ,2 ]
Lee, J. H.
Cho, W. S. [1 ]
Jeung, Y. I. [1 ]
Park, J. H. [2 ]
Jeung, K. S. [3 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Pusan, South Korea
[2] Pusan Bongsaeng Hosp, Pusan, South Korea
[3] Jinju Korea Hosp, Jinju, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:196 / 197
页数:2
相关论文
共 50 条
  • [41] SAFETY OF HIGH-DOSE OF NAFAMOSTAT MESILATE - TOXICOLOGICAL STUDY IN BEAGLES
    OKAMOTO, T
    MIZOGUCHI, S
    TERASAKI, H
    MORIOKA, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (02): : 639 - 644
  • [42] Intravenous injection of low-dose flurbiprofen axetil for preventing post-ERCP pancreatitis in high-risk patients: An interim analysis of the trial
    Fujita, Yuji
    Hasegawa, Sho
    Kato, Yuri
    Ishii, Ken
    Iwasaki, Akito
    Sato, Takamitsu
    Sekino, Yusuke
    Hosono, Kunihiro
    Nakajima, Atsushi
    Kubota, Kensuke
    ENDOSCOPY INTERNATIONAL OPEN, 2016, 4 (10) : E1078 - E1082
  • [43] Role of rectal diclofenac suppository for prevention and its impact on severity of post-ERCP pancreatitis in high risk patients
    Patil, Sandeep
    Pandey, Vikas
    Pandav, Nilesh
    Ingle, Meghraj
    Phadke, Aniruddha
    Sawant, Prabha
    INTERNATIONAL JOURNAL OF HEPATOBILIARY AND PANCREATIC DISEASES, 2015, 5 (02): : 97 - 102
  • [44] Comparison of 24-hour and 8-hour Infusion of Nafamostat Mesilate for the Prevention of Post-ERCP Pancreatitis: A Prospective Randomized Comparison Trial
    Kim, S. J.
    Kang, D. H.
    Kim, H. W.
    Choi, C. W.
    Park, S. B.
    Song, B. J.
    Shin, Y. S.
    PANCREAS, 2014, 43 (08) : 1378 - 1378
  • [45] Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study
    Yin, He-Kun
    Wu, Hai-En
    Li, Qi-Xiang
    Wang, Wei
    Ou, Wei-Lin
    Xia, Harry Hua-Xiang
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [46] A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine versus Rectal Indomethacin Alone for the Prevention of Post-ERCP Pancreatitis in High-Risk Patients
    Kamal, Ayesha
    Akshintala, Venkata
    Talukdar, Rupjyoti
    Goenka, Mahesh K.
    Kochhar, Rakesh
    Sinha, Saroj
    Goud, Rajesh
    Kumar, Vijay
    Elmunzer, B. Joseph
    Khashab, Mouen
    Kalloo, Anthony N.
    Reddy, Duvvur Nageshwar
    Singh, Vikesh K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S429 - S429
  • [47] Analysis of risk factors and prevention strategies of post-ERCP pancreatitis
    Lin, Y.
    Liu, X.
    Ca, D. -Q.
    Tang, J. -H.
    Wen, J. -J.
    Li, T. -F.
    Liu, P. -F.
    Xia, T. -S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (22) : 5185 - 5190
  • [48] Oral Udenafil and Aceclofenac for the Prevention of Post-ERCP Pancreatitis in High-Risk Patients: A Randomized, Placebo-Controlled, Double Blind, Multicenter Study
    Oh, H. -C.
    Choi, J. S.
    Lee, T. Y.
    Song, T. J.
    Do, J. H.
    Cheon, Y. K.
    PANCREAS, 2014, 43 (08) : 1397 - 1397
  • [49] A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine versus Rectal Indomethacin Alone for the Prevention of Post-ERCP Pancreatitis in High-Risk Patients
    Kamal, Ayesha
    Akshintala, Venkata
    Talukdar, Rupjyoti
    Goenka, Mahesh K.
    Kochhar, Rakesh
    Sinha, Saroj
    Goud, Rajesh
    Kumar, Vijay
    Elmunzer, B. Joseph
    Khashab, Mouen
    Kalloo, Anthony N.
    Reddy, Duvvur Nageshwar
    Singh, Vikesh K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S429 - S430
  • [50] A 25 mg rectal dose of diclofenac for prevention of post-ERCP pancreatitis in elderly patients
    Maeda, Natsumi
    Higashimori, Akira
    Nakatani, Masami
    Mizuno, Yuki
    Nakamura, Yoshihiro
    Ikeda, Daisuke
    Maruyama, Hirotsugu
    Morimoto, Kenichi
    Fukuda, Takashi
    Watanabe, Toshio
    Fujiwara, Yasuhiro
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (09) : 1109 - 1116